Cargando…
Preparation of pancreatic β-cells from human iPS cells with small molecules
Human induced pluripotent stem (iPS) cells obtained from patients are expected to be a useful source for cell transplantation therapy, because many patients (including those with type 1 diabetes and severe type 2 diabetes) are on waiting lists for transplantation for a long time due to the shortage...
Autor principal: | Hosoya, Masaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442823/ https://www.ncbi.nlm.nih.gov/pubmed/22722666 http://dx.doi.org/10.4161/isl.20856 |
Ejemplares similares
-
Human iPS cell models of Jervell and Lange-Nielsen syndrome
por: Bellin, Milena, et al.
Publicado: (2015) -
Identification of small molecules for human hepatocyte expansion and iPS differentiation
por: Shan, Jing, et al.
Publicado: (2013) -
Addendum: LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin’s lymphoma models and in cells deficient in DNA damage repair
por: Zhou, Jianli, et al.
Publicado: (2023) -
Small-Molecule Induction Promotes Corneal Endothelial Cell Differentiation From Human iPS Cells
por: Chen, Jie, et al.
Publicado: (2021) -
Drug-Induced Naïve iPS Cells Exhibit Better Performance than Primed iPS Cells with Respect to the Ability to Differentiate into Pancreatic β-Cell Lineage
por: Kiyokawa, Yuki, et al.
Publicado: (2020)